Contamination control is the difference between batch release and batch rejection
Even minor contamination can halt production, compromise sterility assurance, delay batch release, and trigger costly investigations.
Pharmaceutical environments demand decontamination methods that reach beyond surface cleaning to protect product integrity, regulatory compliance, and aseptic confidence.
Decon+ delivers validation-grade microbial control built for the realities of sterile manufacturing.
- Proven kill of bacteria, viruses, molds, and spores
- Full-facility penetration—including isolators, HVAC ductwork, HEPA filters, and enclosed systems
- No measurable residue on sensitive equipment or materials
- Faster cycles to support turnaround and production scheduling
Speed, assurance, and flexibility protect pharmaceutical manufacturing operations
Production doesn’t stop for complex cleanroom geometries, integrated equipment, or tightening regulatory expectations.
Effective decontamination must penetrate hidden spaces, maintain material compatibility, and deliver documentation that withstands audits.
Decon+ achieves this with true gas-phase penetration, rapid UV treatment for open surfaces, and validation-grade monitoring that verifies microbial reduction across critical environments.
Our methods integrate seamlessly into existing cleaning and sterilization workflows and adapt to each facility’s classification, layout, and throughput expectations.
Reliable decontamination in pharmaceutical environments helps keeps your operations compliant.
Connect with a Decon+ Specialist